ATHX vs. GRI, EVFM, CMRA, VRPX, SPRC, SBFM, HSTO, BLPH, SXTC, and ADTX
Should you be buying Athersys stock or one of its competitors? The main competitors of Athersys include GRI Bio (GRI), Evofem Biosciences (EVFM), Comera Life Sciences (CMRA), Virpax Pharmaceuticals (VRPX), SciSparc (SPRC), Sunshine Biopharma (SBFM), Histogen (HSTO), Bellerophon Therapeutics (BLPH), China SXT Pharmaceuticals (SXTC), and Aditxt (ADTX). These companies are all part of the "pharmaceutical preparations" industry.
Athersys (NASDAQ:ATHX) and GRI Bio (NASDAQ:GRI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends.
Athersys received 365 more outperform votes than GRI Bio when rated by MarketBeat users.
Athersys has a beta of -0.9, indicating that its share price is 190% less volatile than the S&P 500. Comparatively, GRI Bio has a beta of -1.55, indicating that its share price is 255% less volatile than the S&P 500.
In the previous week, GRI Bio had 1 more articles in the media than Athersys. MarketBeat recorded 2 mentions for GRI Bio and 1 mentions for Athersys. GRI Bio's average media sentiment score of 0.02 beat Athersys' score of 0.00 indicating that GRI Bio is being referred to more favorably in the news media.
GRI Bio has lower revenue, but higher earnings than Athersys.
19.4% of Athersys shares are owned by institutional investors. Comparatively, 34.0% of GRI Bio shares are owned by institutional investors. 0.0% of Athersys shares are owned by insiders. Comparatively, 3.0% of GRI Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Athersys' return on equity of 0.00% beat GRI Bio's return on equity.
Summary
Athersys and GRI Bio tied by winning 5 of the 10 factors compared between the two stocks.
Get Athersys News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATHX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Athersys Competitors List
Related Companies and Tools
